Condition
Stage IV Malignant Mesothelioma
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 2 (1)
Trial Status
Completed2
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT01503177Phase 1Completed
Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma
NCT02106559Not ApplicableWithdrawn
Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy
NCT00107432Phase 2Completed
Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.
Showing all 3 trials